Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medtronic Plc (MDT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Medtronic Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1613103.
Total stock buying since 2015: $7,204,517.
Total stock sales since 2015: $208,566,487.
Total stock option exercises since 2015: $118,235,728.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 5,000 | $462,750 | 22,287 | $1,911,368 | 206,389 | $8,705,737 |
| 2024 | 0 | $0 | 50,662 | $4,284,930 | 108,667 | $3,280,434 |
| 2023 | 0 | $0 | 24,863 | $2,099,468 | 5,514 | $305,034 |
| 2022 | 0 | $0 | 30,525 | $2,633,590 | 23,843 | $1,220,044 |
| 2021 | 5,010 | $517,332 | 209,183 | $26,826,248 | 206,926 | $13,774,963 |
| 2020 | 13,378 | $1,497,038 | 93,246 | $10,343,535 | 43,242 | $2,680,090 |
| 2019 | 30,900 | $2,833,760 | 438,861 | $46,964,583 | 473,188 | $27,305,497 |
| 2018 | 2,600 | $249,285 | 422,775 | $38,918,147 | 459,210 | $19,823,835 |
| 2017 | 5,600 | $497,840 | 398,480 | $32,677,800 | 313,698 | $13,659,621 |
| 2016 | 15,660 | $1,146,512 | 314,638 | $26,505,530 | 533,517 | $19,638,309 |
| 2015 | 0 | $0 | 200,736 | $15,401,288 | 155,492 | $7,842,164 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 5,000 | $462,750 | 0 | $0 | 148,679 | $4,347,421 |
| 2025-01 | 0 | $0 | 22,287 | $1,911,368 | 57,710 | $4,358,316 |
| 2024-08 | 0 | $0 | 0 | $0 | 58,367 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 492 | $30,877 |
| 2024-06 | 0 | $0 | 19,113 | $1,601,478 | 19,113 | $1,199,531 |
| 2024-04 | 0 | $0 | 854 | $71,001 | 0 | $0 |
| 2024-02 | 0 | $0 | 30,695 | $2,612,451 | 30,695 | $2,050,026 |
| 2023-12 | 0 | $0 | 4,997 | $410,603 | 0 | $0 |
| 2023-08 | 0 | $0 | 12,352 | $1,035,496 | 0 | $0 |
| 2023-07 | 0 | $0 | 7,514 | $653,369 | 5,514 | $305,034 |
| 2022-12 | 0 | $0 | 16,631 | $1,338,728 | 16,631 | $920,026 |
| 2022-10 | 0 | $0 | 7,212 | $588,042 | 7,212 | $300,018 |
| 2022-03 | 0 | $0 | 6,682 | $706,820 | 0 | $0 |
| 2021-12 | 5,010 | $517,332 | 7,900 | $811,544 | 0 | $0 |
| 2021-09 | 0 | $0 | 49,147 | $6,221,027 | 49,147 | $3,833,466 |
| 2021-08 | 0 | $0 | 94,775 | $12,685,573 | 90,775 | $5,580,915 |
| 2021-06 | 0 | $0 | 3,193 | $406,223 | 1,168 | $87,413 |
| 2021-05 | 0 | $0 | 34,656 | $4,389,182 | 46,956 | $3,455,587 |
| 2021-04 | 0 | $0 | 11,712 | $1,391,736 | 11,712 | $567,563 |
| 2021-03 | 0 | $0 | 7,800 | $920,963 | 7,168 | $250,019 |
| 2020-12 | 0 | $0 | 29,205 | $3,363,111 | 0 | $0 |
| 2020-11 | 0 | $0 | 20,715 | $2,343,487 | 20,715 | $1,300,073 |
| 2020-10 | 4,607 | $499,951 | 21,477 | $2,361,249 | 20,714 | $1,300,010 |
| 2020-09 | 0 | $0 | 19,849 | $2,080,248 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-25 | Jellison William R (Director) | Buy | 2,500 | 92.37 | 230,925 |
| 2025-08-22 | Jellison William R (Director) | Buy | 2,500 | 92.73 | 231,825 |
| 2025-08-01 | Blomquist Denise L. (Chief Accounting Officer) | Option Ex | 518 | 26.00 | 13,468 |
| 2025-08-01 | Walter Matthew R. (SVP, Chief HR Officer) | Option Ex | 3,142 | 39.00 | 122,538 |
| 2025-08-01 | Marinaro Michael (EVP, Pres MedSurg and Americas) | Option Ex | 9,661 | 39.00 | 376,779 |
| 2025-08-01 | Kiil Harry Skip (EVP & President Cardiovascular) | Option Ex | 10,457 | .00 | 0 |
| 2025-08-01 | Martha Geoffrey (Chairman and CEO) | Option Ex | 98,324 | 39.00 | 3,834,636 |
| 2025-08-01 | Smith Gregory L (EVP Global Ops & Supply Chain) | Option Ex | 11,328 | .00 | 0 |
| 2025-08-01 | Wall Brett A. (EVP & Pres Neuroscience) | Option Ex | 15,249 | .00 | 0 |
| 2025-01-27 | Walter Matthew R. (SVP, Chief HR Officer) | Option Ex | 1,337 | 74.84 | 100,061 |
| 2025-01-27 | Marinaro Michael (EVP & President, Surgical OU) | Option Ex | 2,345 | 74.84 | 175,499 |
| 2025-01-27 | Martha Geoffrey (Chairman and CEO) | Option Ex | 34,741 | 74.84 | 2,600,016 |
| 2025-01-24 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 12,437 | 90.00 | 1,119,330 |
| 2025-01-24 | Wall Brett A. (EVP & Pres Neuroscience) | Option Ex | 12,437 | 78.00 | 970,086 |
| 2025-01-08 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 9,850 | 80.41 | 792,038 |
| 2025-01-08 | Wall Brett A. (EVP & Pres Neuroscience) | Option Ex | 6,850 | 74.84 | 512,654 |
| 2024-08-02 | Walter Matthew R. (SVP, Chief HR Officer) | Option Ex | 684 | .00 | 0 |
| 2024-08-02 | Marinaro Michael (EVP & President, Surgical OU) | Option Ex | 1,670 | .00 | 0 |
| 2024-08-02 | Salmon Sean (EVP & President Cardiovascular) | Option Ex | 5,462 | .00 | 0 |
| 2024-08-02 | Kirk Jennifer M (Chief Accounting Officer) | Option Ex | 1,138 | .00 | 0 |
| 2024-08-02 | Martha Geoffrey (Chairman and CEO) | Option Ex | 18,966 | .00 | 0 |
| 2024-08-02 | Smith Gregory L (EVP Global Ops & Supply Chain) | Option Ex | 3,490 | .00 | 0 |
| 2024-08-02 | Parkhill Karen L (EVP & Chief Financial Officer) | Option Ex | 7,132 | .00 | 0 |
| 2024-08-02 | Wall Brett A. (EVP & Pres Neuroscience) | Option Ex | 5,311 | .00 | 0 |
| 2024-08-02 | Fong Ivan K (EVP GENERAL COUNSEL & SECR) | Option Ex | 14,514 | .00 | 0 |
| 2024-07-18 | Walter Matthew R. (SVP, Chief HR Officer) | Option Ex | 492 | 62.76 | 30,877 |
| 2024-06-07 | Martha Geoffrey (Chairman and CEO) | Sale | 19,113 | 83.79 | 1,601,478 |
| 2024-06-07 | Martha Geoffrey (Chairman and CEO) | Option Ex | 19,113 | 62.76 | 1,199,531 |
| 2024-04-08 | Marinaro Michael (EVP & President, Surgical OU) | Sale | 854 | 83.14 | 71,001 |
| 2024-02-21 | Salmon Sean (EVP & President Cardiovascular) | Sale | 30,695 | 85.11 | 2,612,451 |
| 2024-02-21 | Salmon Sean (EVP & President Cardiovascular) | Option Ex | 30,695 | 66.79 | 2,050,026 |
| 2023-12-19 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 4,997 | 82.17 | 410,603 |
| 2023-08-23 | Smith Gregory L (EVP Global Ops & Supply Chain) | Sale | 10,000 | 83.84 | 838,400 |
| 2023-08-14 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 1,000 | 83.38 | 83,380 |
| 2023-08-04 | Marinaro Michael (EVP & President, Surgical OU) | Sale | 1,352 | 84.11 | 113,716 |
| 2023-07-14 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 2,000 | 87.97 | 175,940 |
| 2023-07-10 | Ten Hoedt Rob (EVP and Pres. Global Regions) | Sale | 5,514 | 86.58 | 477,429 |
| 2023-07-10 | Ten Hoedt Rob (EVP and Pres. Global Regions) | Option Ex | 5,514 | 55.32 | 305,034 |
| 2022-12-13 | Salmon Sean (EVP & President Cardiovascular) | Sale | 16,631 | 80.50 | 1,338,728 |
| 2022-12-13 | Salmon Sean (EVP & President Cardiovascular) | Option Ex | 16,631 | 55.32 | 920,026 |
| 2022-10-14 | Ten Hoedt Rob (EVP and Pres. Global Regions) | Sale | 4,808 | 81.54 | 392,028 |
| 2022-10-14 | Ten Hoedt Rob (EVP and Pres. Global Regions) | Option Ex | 4,808 | 41.60 | 200,012 |
| 2022-03-18 | Parkhill Karen L (EVP & Chief Financial Officer) | Sale | 682 | 110.00 | 75,020 |
| 2022-03-11 | Surface Carol A (SVP, Chief HR Officer) | Sale | 6,000 | 105.30 | 631,800 |
| 2021-12-23 | White Robert John (EVP & Pres. Medical Surgical) | Sale | 7,218 | 102.04 | 736,524 |
| 2021-12-16 | Anderson Richard H (Director) | Buy | 5,010 | 103.26 | 517,332 |
| 2021-12-06 | Parkhill Karen L (EVP & Chief Financial Officer) | Sale | 682 | 110.00 | 75,020 |
| 2021-09-30 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 49,147 | 126.58 | 6,221,027 |
| 2021-09-30 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Option Ex | 49,147 | 78.00 | 3,833,466 |
| 2021-08-31 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 50,775 | 134.17 | 6,812,481 |
| 2021-08-31 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Option Ex | 50,775 | 74.84 | 3,800,001 |
| 2021-08-25 | Salmon Sean (EVP & Pres Diabetes/Cardiovasc) | Sale | 28,419 | 134.09 | 3,810,561 |
| 2021-08-25 | Salmon Sean (EVP & Pres Diabetes/Cardiovasc) | Option Ex | 28,419 | 38.61 | 1,097,172 |
| 2021-08-25 | Martha Geoffrey (CEO) | Sale | 11,581 | 132.67 | 1,536,451 |
| 2021-08-25 | Martha Geoffrey (CEO) | Option Ex | 11,581 | 59.04 | 683,742 |
| 2021-08-02 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 4,000 | 131.52 | 526,080 |
| 2021-06-21 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 115 | 123.50 | 14,202 |
| 2021-06-18 | Wall Brett A. (EVP & Pres Neuroscience) | Option Ex | 1,168 | 74.84 | 87,413 |
| 2021-06-15 | Parkhill Karen L (EVP & Chief Financial Officer) | Sale | 605 | 124.47 | 75,304 |
| 2021-06-01 | Wall Brett A. (EVP & Pres Neuroscience) | Sale | 2,473 | 128.07 | 316,717 |
| 2021-05-28 | Liddicoat John R (EVP & President of Americas) | Sale | 34,656 | 126.65 | 4,389,182 |
| 2021-05-28 | Liddicoat John R (EVP & President of Americas) | Option Ex | 34,656 | 83.03 | 2,877,487 |
| 2021-05-28 | Wall Brett A. (EVP & Pres Neuroscience) | Option Ex | 12,300 | 47.00 | 578,100 |
| 2021-04-05 | Martha Geoffrey (CEO) | Sale | 11,712 | 118.83 | 1,391,736 |
| 2021-04-05 | Martha Geoffrey (CEO) | Option Ex | 11,712 | 48.46 | 567,563 |
| 2021-03-15 | Parkhill Karen L (EVP & Chief Financial Officer) | Sale | 632 | 119.12 | 75,283 |
| 2021-03-02 | Ten Hoedt Rob (EVP & President EMEA) | Sale | 7,168 | 117.98 | 845,680 |
| 2021-03-02 | Ten Hoedt Rob (EVP & President EMEA) | Option Ex | 7,168 | 34.88 | 250,019 |
| 2020-12-28 | Surface Carol A (SVP, Chief HR Officer) | Sale | 15,000 | 114.90 | 1,723,500 |
| 2020-12-22 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 2,605 | 115.56 | 301,033 |
| 2020-12-18 | White Robert John (EVP & Pres. Medical Surgical) | Sale | 10,930 | 115.46 | 1,261,977 |
| 2020-12-15 | Parkhill Karen L (EVP & Chief Financial Officer) | Sale | 670 | 114.33 | 76,601 |
| 2020-11-09 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 20,715 | 113.13 | 2,343,487 |
| 2020-11-09 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Option Ex | 20,715 | 62.76 | 1,300,073 |
| 2020-10-09 | Ishrak Omar (Executive Chairman) | Sale | 763 | 108.40 | 82,709 |
| 2020-10-08 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 20,714 | 110.00 | 2,278,540 |
| 2020-10-08 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Option Ex | 20,714 | 62.76 | 1,300,010 |
| 2020-10-08 | Anderson Richard H (Director) | Buy | 4,607 | 108.52 | 499,951 |
| 2020-09-23 | Ten Hoedt Rob (EVP & President EMEA) | Sale | 9,584 | 104.34 | 999,994 |
| 2020-09-15 | Parkhill Karen L (EVP & Chief Financial Officer) | Sale | 702 | 107.78 | 75,661 |
| 2020-09-09 | Ten Hoedt Rob (EVP & President EMEA) | Sale | 9,563 | 105.05 | 1,004,593 |
| 2020-05-29 | Surface Carol A (SVP, Chief HR Officer) | Sale | 2,000 | 97.72 | 195,440 |
| 2020-04-03 | Oleary Denise M (Director) | Option Ex | 1,813 | 44.13 | 80,007 |
| 2020-02-20 | Ishrak Omar (Chairman & CEO) | Buy | 8,771 | 113.68 | 997,087 |
| 2019-12-24 | Kuntz Richard (SVP & Chief Medical & Science) | Sale | 50,856 | 113.62 | 5,778,157 |
| 2019-12-24 | Kuntz Richard (SVP & Chief Medical & Science) | Option Ex | 42,770 | 50.75 | 2,170,449 |
| 2019-12-06 | Anderson Richard H (Director) | Buy | 5,000 | 113.29 | 566,450 |
| 2019-12-02 | White Robert John (EVP & President MITG) | Sale | 52,166 | 110.63 | 5,771,020 |
| 2019-12-02 | White Robert John (EVP & President MITG) | Option Ex | 52,166 | 60.92 | 3,177,952 |
| 2019-11-15 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Sale | 36,874 | 111.32 | 4,104,924 |
| 2019-11-15 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Option Ex | 36,874 | 38.81 | 1,431,079 |
| 2019-11-14 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Sale | 2,102 | 109.74 | 230,667 |
| 2019-11-14 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Option Ex | 2,102 | 40.20 | 84,510 |
| 2019-11-01 | White Robert John (EVP & President MITG) | Sale | 52,165 | 109.44 | 5,709,041 |
| 2019-11-01 | White Robert John (EVP & President MITG) | Option Ex | 52,165 | 37.70 | 1,966,620 |
| 2019-11-01 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Sale | 38,976 | 109.50 | 4,267,872 |
| 2019-11-01 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Option Ex | 38,976 | 40.20 | 1,567,030 |
| 2019-10-11 | Surface Carol A (SVP, Chief HR Officer) | Option Ex | 84,207 | 78.20 | 6,584,734 |
| 2019-10-01 | White Robert John (EVP & President MITG) | Option Ex | 52,165 | 27.41 | 1,429,686 |
| 2019-09-27 | Kuntz Richard (SVP & Chief Medical & Science) | Sale | 21,425 | 107.86 | 2,310,921 |
| 2019-09-25 | Lenehan James T (Director) | Option Ex | 1,813 | 44.13 | 80,007 |
| 2019-09-10 | Hakami Hooman (EVP & Group President Diabetes) | Sale | 82,877 | 107.26 | 8,889,718 |
| 2019-09-10 | Hakami Hooman (EVP & Group President Diabetes) | Option Ex | 72,877 | 84.78 | 6,178,366 |
| 2019-08-05 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 4,000 | 100.31 | 401,240 |
| 2019-08-02 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 6,599 | 102.02 | 673,229 |
| 2019-08-02 | Kuntz Richard (SVP & Chief Medical & Science) | Sale | 5,719 | 102.02 | 583,452 |
| 2019-07-22 | Kuntz Richard (SVP & Chief Medical & Science) | Sale | 3,438 | 101.12 | 347,650 |
| 2019-06-17 | Surface Carol A (SVP, Chief HR Officer) | Sale | 9,000 | 97.66 | 878,976 |
| 2019-06-12 | Hakami Hooman (EVP & Group President Diabetes) | Sale | 52,664 | 97.49 | 5,134,213 |
| 2019-06-12 | Hakami Hooman (EVP & Group President Diabetes) | Option Ex | 31,731 | 78.00 | 2,475,018 |
| 2019-06-06 | Martha Geoffrey (EVP & GroupPres Restora Therap) | Sale | 11,000 | 96.05 | 1,056,583 |
| 2019-05-28 | Ten Hoedt Rob (EVP & President EMEA) | Sale | 9,000 | 91.88 | 826,920 |
| 2019-05-24 | Anderson Richard H (Director) | Buy | 10,900 | 92.40 | 1,007,160 |
| 2019-04-01 | Oleary Denise M (Director) | Option Ex | 2,671 | 29.96 | 80,023 |
| 2019-03-04 | Lenehan James T (Director) | Option Ex | 2,671 | 29.96 | 80,023 |
| 2019-01-09 | Parkhill Karen L (EVP & Chief Financial Officer) | Buy | 3,000 | 83.87 | 251,610 |
| 2019-01-09 | Ishrak Omar (Chairman & CEO) | Buy | 12,000 | 84.05 | 1,008,540 |
| 2018-09-24 | Martha Geoffrey (EVP & GroupPres Restora Therap) | Sale | 49,799 | 97.93 | 4,876,666 |
| 2018-09-24 | Martha Geoffrey (EVP & GroupPres Restora Therap) | Option Ex | 49,799 | 36.84 | 1,834,844 |
| 2018-08-31 | Hakami Hooman (EVP & Group President Diabetes) | Sale | 26,159 | 96.29 | 2,518,797 |
| 2018-08-31 | Hakami Hooman (EVP & Group President Diabetes) | Option Ex | 26,159 | 62.76 | 1,641,738 |
| 2018-08-28 | Kuntz Richard (SVP & Chief Medical & Science) | Sale | 47,176 | 95.88 | 4,523,093 |
| 2018-08-28 | Kuntz Richard (SVP & Chief Medical & Science) | Option Ex | 41,227 | 38.81 | 1,600,019 |
| 2018-08-23 | Pozen Robert C (Director) | Sale | 3,218 | 95.94 | 308,738 |
| 2018-08-23 | Pozen Robert C (Director) | Option Ex | 4,484 | 37.05 | 166,109 |
| 2018-08-23 | Anderson Richard H (Director) | Buy | 2,600 | 95.88 | 249,285 |
| 2018-08-22 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Sale | 145,544 | 95.50 | 13,899,160 |
| 2018-08-22 | Coyle Michael J (EVP & Group Pres, Cardiac&Vasc) | Option Ex | 178,219 | 38.52 | 6,864,995 |
| 2018-06-11 | Lerman Bradley E (SVP General Counsel & Corp Sec) | Sale | 8,910 | 86.82 | 773,566 |
| 2018-06-08 | Kuntz Richard (SVP & Chief Medical & Science) | Sale | 11,500 | 87.13 | 1,001,995 |
| 2018-04-17 | Oleary Denise M (Director) | Option Ex | 1,590 | 50.34 | 80,040 |
| 2018-03-13 | Lenehan James T (Director) | Sale | 1,306 | 83.56 | 109,122 |
| 2018-03-13 | Lenehan James T (Director) | Option Ex | 1,590 | 50.34 | 80,040 |
| 2018-03-05 | Surface Carol A (SVP, Chief HR Officer) | Sale | 12,479 | 78.36 | 977,854 |
| 2018-03-05 | Surface Carol A (SVP, Chief HR Officer) | Option Ex | 48,620 | 61.06 | 2,968,591 |
| 2018-03-02 | Surface Carol A (SVP, Chief HR Officer) | Sale | 12,000 | 78.00 | 936,000 |
| 2018-01-09 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 78,526 | 86.21 | 6,769,726 |
| 2018-01-09 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Option Ex | 81,364 | 36.20 | 2,945,783 |
| 2018-01-05 | Hakami Hooman (EVP & Group President Diabetes) | Sale | 26,158 | 85.00 | 2,223,430 |
| 2018-01-05 | Hakami Hooman (EVP & Group President Diabetes) | Option Ex | 26,158 | 62.76 | 1,641,676 |
| 2017-12-15 | Hanson Bryan C (EVP, President, MITG) | Sale | 16,000 | 82.82 | 1,325,120 |
| 2017-11-16 | Hanson Bryan C (EVP, President, MITG) | Sale | 16,000 | 79.02 | 1,264,320 |
| 2017-10-16 | Hanson Bryan C (EVP, President, MITG) | Sale | 16,000 | 78.03 | 1,248,480 |
| 2017-09-15 | Ishrak Omar (Chairman & CEO) | Sale | 140,407 | 81.63 | 11,461,423 |
| 2017-09-15 | Ishrak Omar (Chairman & CEO) | Option Ex | 100,000 | 38.81 | 3,881,000 |
| 2017-08-25 | Oleary Denise M (Director) | Option Ex | 1,010 | 52.84 | 53,368 |
| 2017-07-17 | Hanson Bryan C (EVP, President, MITG) | Sale | 12,000 | 88.57 | 1,062,840 |
| 2017-07-10 | Lenehan James T (Director) | Option Ex | 1,010 | 52.84 | 53,368 |
| 2017-06-21 | Anderson Richard H (Director) | Buy | 5,600 | 88.90 | 497,840 |
| 2017-03-20 | Ten Hoedt Rob (EVP & President EMEA) | Sale | 50,757 | 81.58 | 4,140,603 |
| 2017-03-20 | Ten Hoedt Rob (EVP & President EMEA) | Option Ex | 50,757 | 48.60 | 2,467,043 |
| 2017-03-15 | Ishrak Omar (Chairman & CEO) | Sale | 95,000 | 82.82 | 7,867,995 |
| 2017-03-15 | Ishrak Omar (Chairman & CEO) | Option Ex | 75,000 | 38.81 | 2,910,750 |
| 2017-03-02 | Hakami Hooman (EVP & Group President Diabetes) | Sale | 52,316 | 82.33 | 4,307,019 |
| 2017-03-02 | Hakami Hooman (EVP & Group President Diabetes) | Option Ex | 52,316 | 62.76 | 3,283,352 |
| 2017-03-02 | Hogan Randall J (Director) | Option Ex | 15,109 | 27.38 | 413,684 |
| 2017-03-01 | Arnold Craig (Director) | Option Ex | 15,109 | 27.38 | 413,684 |
| 2017-01-05 | Lenehan James T (Director) | Option Ex | 3,387 | 54.14 | 183,372 |
| 2016-12-13 | Pozen Robert C (Director) | Buy | 13,660 | 73.20 | 999,980 |
| 2016-11-23 | Lenehan James T (Director) | Buy | 2,000 | 73.27 | 146,532 |
| 2016-09-27 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 17,141 | 86.70 | 1,486,056 |
| 2016-09-26 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 25,199 | 86.67 | 2,183,997 |
| 2016-09-26 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Option Ex | 30,624 | 35.92 | 1,100,014 |
| 2016-09-15 | Ishrak Omar (Chairman & CEO) | Sale | 61,925 | 84.93 | 5,259,414 |
| 2016-09-15 | Powell Kendall J (Director) | Sale | 7,907 | 85.44 | 675,613 |
| 2016-09-15 | Powell Kendall J (Director) | Option Ex | 10,061 | 45.78 | 460,552 |
| 2016-08-29 | Hanson Bryan C (EVP, President, MITG) | Sale | 15,000 | 87.00 | 1,305,000 |
| 2016-08-29 | Hanson Bryan C (EVP, President, MITG) | Option Ex | 15,000 | 29.52 | 442,800 |
| 2016-08-16 | Oleary Denise M (Director) | Option Ex | 1,493 | 46.91 | 70,036 |
| 2016-07-26 | Hanson Bryan C (EVP, President, MITG) | Sale | 15,000 | 87.00 | 1,305,000 |
| 2016-07-26 | Hanson Bryan C (EVP, President, MITG) | Option Ex | 15,000 | 29.52 | 442,800 |
| 2016-07-15 | Martha Geoffrey (EVP & GroupPres Restora Therap) | Sale | 3,766 | 88.26 | 332,402 |
| 2016-07-13 | Ellis Gary Lee (EVP & Global Ops and IT) | Sale | 35,495 | 88.64 | 3,146,205 |
| 2016-07-13 | Ellis Gary Lee (EVP & Global Ops and IT) | Option Ex | 41,068 | 48.70 | 2,000,011 |
| 2016-07-13 | Jackson Shirley A (Director) | Sale | 2,104 | 88.64 | 186,498 |
| 2016-07-13 | Jackson Shirley A (Director) | Option Ex | 2,600 | 51.59 | 134,134 |
| 2016-07-06 | Surface Carol A (SVP, Chief HR Officer) | Sale | 9,787 | 87.08 | 852,271 |
| 2016-07-05 | Hanson Bryan C (EVP, President, MITG) | Sale | 15,272 | 87.11 | 1,330,343 |
| 2016-07-05 | Hanson Bryan C (EVP, President, MITG) | Option Ex | 15,272 | 27.29 | 416,772 |
| 2016-06-24 | Anderson Richard H (Director) | Option Ex | 8,577 | 44.84 | 384,558 |
| 2016-06-03 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 49,905 | 82.60 | 4,122,152 |
| 2016-06-03 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Option Ex | 58,900 | 42.01 | 2,474,094 |
| 2016-06-01 | Ten Hoedt Rob (EVP & President EMEAC) | Sale | 12,100 | 80.54 | 974,546 |
| 2016-06-01 | Ten Hoedt Rob (EVP & President EMEAC) | Option Ex | 10,416 | 36.08 | 375,809 |
| 2016-04-01 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 4,000 | 75.22 | 300,880 |
| 2016-03-18 | Jackson Shirley A (Director) | Sale | 1,238 | 75.60 | 93,592 |
| 2016-03-18 | Jackson Shirley A (Director) | Option Ex | 1,493 | 46.91 | 70,036 |
| 2016-03-17 | Ishrak Omar (Chairman & CEO) | Sale | 23,799 | 76.51 | 1,820,861 |
| 2016-03-15 | Ishrak Omar (Chairman & CEO) | Option Ex | 323,013 | 34.88 | 11,266,693 |
| 2016-03-04 | Hanson Bryan C (EVP, President, MITG) | Sale | 5,000 | 75.00 | 375,000 |
| 2016-02-05 | Hanson Bryan C (EVP, President, MITG) | Sale | 5,000 | 76.14 | 380,700 |
| 2016-01-08 | Hanson Bryan C (EVP & Pres Min Invas Therapies) | Sale | 5,000 | 75.00 | 375,000 |
| 2015-12-04 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 13,715 | 78.06 | 1,070,647 |
| 2015-12-04 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Option Ex | 15,401 | 48.70 | 750,028 |
| 2015-09-15 | Ishrak Omar (Chairman & CEO) | Sale | 20,000 | 69.43 | 1,388,660 |
| 2015-08-24 | Oleary Denise M | Option Ex | 5,440 | 56.99 | 310,052 |
| 2015-07-14 | Surface Carol A (SVP, Chief HR Officer) | Sale | 13,722 | 75.83 | 1,040,539 |
| 2015-07-14 | Surface Carol A (SVP, Chief HR Officer) | Option Ex | 8,239 | 57.65 | 474,978 |
| 2015-06-10 | Anderson Richard H | Option Ex | 5,440 | 56.99 | 310,052 |
| 2015-04-06 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Sale | 31,768 | 77.39 | 2,458,652 |
| 2015-04-06 | Kuntz Richard (SrVP & Chief Scien, Clin, Reg) | Option Ex | 35,447 | 55.10 | 1,953,306 |
| 2015-03-25 | Ellis Gary Lee (EVP & Chief Financial Officer) | Sale | 43,183 | 77.81 | 3,360,155 |
| 2015-03-25 | Ellis Gary Lee (EVP & Chief Financial Officer) | Option Ex | 37,011 | 56.74 | 2,100,004 |
| 2015-03-18 | Ten Hoedt Rob (EVP & President EMEAC) | Sale | 7,619 | 77.41 | 589,794 |
| 2015-03-13 | Ishrak Omar (Chairman & CEO) | Sale | 20,000 | 76.24 | 1,524,740 |
| 2015-02-26 | Oleary Denise M | Sale | 368 | 78.85 | 29,017 |
| 2015-02-19 | Oconnell Christopher J (EVP & GroupPres Restora Therap) | Sale | 29,791 | 78.17 | 2,328,762 |
| 2015-02-19 | Oconnell Christopher J (EVP & GroupPres Restora Therap) | Option Ex | 29,791 | 42.47 | 1,265,223 |
| 2015-02-18 | Oconnell Christopher J (EVP & GroupPres Restora Therap) | Sale | 20,570 | 78.28 | 1,610,322 |
| 2015-02-18 | Oconnell Christopher J (EVP & GroupPres Restora Therap) | Option Ex | 18,723 | 36.24 | 678,521 |
Insider trading activities including stock purchases, stock sales, and option exercises of MDT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medtronic Plc (symbol MDT, CIK number 1613103) see the Securities and Exchange Commission (SEC) website.